Literature DB >> 27506225

Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement.

J Arciniega1, L Wagner1, R Prymula2, P Sebo3, R Isbrucker4, B Descampe5, J M Chapsal6, A Costanzo7, C Hendriksen8, M Hoonaker8, S Nelson6, K Lidster9, W Casey10, D Allen11.   

Abstract

The 'International Workshop on Alternatives to the Murine Histamine Sensitization Test for Acellular Pertussis Vaccines: Progress and Challenges in the Replacement of HIST' was held on 24 August 2014, in Prague, Czech Republic, as a satellite meeting to the 9th World Congress on Alternatives and Animal Use in the Life Sciences. Participants discussed the progress and challenges associated with the development, validation, and implementation of in vitro assays as replacements for the histamine sensitisation test (HIST) for acellular pertussis vaccines. Discussions focused on the consistency approach, the necessary framework for regulatory acceptance of a harmonised method, and recent international efforts towards the development of in vitro assays to replace the HIST. Workshop participants agreed that acceptable alternatives to the HIST should be based on ADP ribosylation-mediated cell intoxication and therefore that the CHO cell clustering assay, which measures cell intoxication, should be further pursued and developed as a possible replacement for the HIST. Participants also agreed to continue ongoing multinational discussions involving national and international standardisation authorities to reach consensus and to organise collaborative studies in this context for assay characterisation and calibration of reference materials.

Entities:  

Keywords:  Pertussis vaccines; histamine sensitisation test; replacement alternative

Mesh:

Substances:

Year:  2016        PMID: 27506225      PMCID: PMC4980995     

Source DB:  PubMed          Journal:  Pharmeur Bio Sci Notes        ISSN: 2075-2164


  29 in total

1.  Determination of the histamine sensitizing unitage of pertussis vaccine.

Authors:  M Pittman
Journal:  J Biol Stand       Date:  1975

2.  CIRCULATORY COLLAPSE IN ANAPHYLAXIS AND HISTAMINE TOXICITY IN MICE.

Authors:  R K BERGMAN; J MUNOZ
Journal:  J Immunol       Date:  1965-07       Impact factor: 5.422

Review 3.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

4.  An in vitro assay system as a potential replacement for the histamine sensitisation test for acellular pertussis based combination vaccines.

Authors:  Chun-Ting Yuen; Yoshinobu Horiuchi; Catpagavalli Asokanathan; Sarah Cook; Alexandra Douglas-Bardsley; Masaki Ochiai; Michael Corbel; Dorothy Xing
Journal:  Vaccine       Date:  2010-03-20       Impact factor: 3.641

5.  Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration.

Authors:  D Xing; R Gaines Das; P Newland; M Corbel
Journal:  Vaccine       Date:  2002-10-04       Impact factor: 3.641

6.  Histamine shock in mice sensitized with Hemophilus pertussis vaccine.

Authors:  I A PARFENTJEV; M A GOODLINE
Journal:  J Pharmacol Exp Ther       Date:  1948-04       Impact factor: 4.030

Review 7.  Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.

Authors:  Nicholas H Carbonetti
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

8.  A sensitive assay method for the histamine-sensitizing factor using change in rectal temperature of mice after histamine challenge as a response.

Authors:  S Ishida; M Kurokawa; S Asakawa; S Iwasa
Journal:  J Biol Stand       Date:  1979-01

9.  Identification of Bphs, an autoimmune disease locus, as histamine receptor H1.

Authors:  Runlin Z Ma; Jianfeng Gao; Nathan D Meeker; Parley D Fillmore; Kenneth S K Tung; Takeshi Watanabe; James F Zachary; Halina Offner; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

10.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Authors:  F R Mooi; I H van Loo; A J King
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

View more
  2 in total

Review 1.  Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.

Authors:  Kevin Markey; Catpagavalli Asokanathan; Ian Feavers
Journal:  Toxins (Basel)       Date:  2019-07-17       Impact factor: 4.546

2.  Safety testing of acellular pertussis vaccines: Use of animals and 3Rs alternatives.

Authors:  Marieke Hoonakker; Juan Arciniega; Coenraad Hendriksen
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.